Abstract
Platinum based chemptherapy improves the cure rate of patients with MGCT to over 80 poer cent, but tumour recurrence is associated with an unfavourable prognosis. We sought to identify factors predicitive of poor outcome following relapse.
Lingua originale | English |
---|---|
Pagine | 135-136 |
Numero di pagine | 2 |
Stato di pubblicazione | Published - 2001 |